<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults - Haywood, A - 2019 | Cochrane Library</title> <meta content="Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults - Haywood, A - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012704.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults - Haywood, A - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012704.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012704.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults" name="citation_title"/> <meta content="Alison Haywood" name="citation_author"/> <meta content="Jacqueline Duc" name="citation_author"/> <meta content="Phillip Good" name="citation_author"/> <meta content="Sohil Khan" name="citation_author"/> <meta content="Kirsty Rickett" name="citation_author"/> <meta content="UQ/Mater McAuley Library" name="citation_author_institution"/> <meta content="Petra Vayne-Bossert" name="citation_author"/> <meta content="University Hospitals of Geneva" name="citation_author_institution"/> <meta content="Janet R Hardy" name="citation_author"/> <meta content="janet.hardy@mater.org.au" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD012704.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/02/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012704.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012704.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012704.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Adrenal Cortex Hormones [administration &amp; dosage, adverse effects, *therapeutic use]; Dexamethasone [administration &amp; dosage, adverse effects, *therapeutic use]; Dyspnea [*drug therapy, etiology]; Neoplasms [*complications]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012704.pub2&amp;doi=10.1002/14651858.CD012704.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="uYcNEb5O";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012704\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012704\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","ms","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012704.pub2",title:"Systemic corticosteroids for the management of cancer\\u2010related breathlessness (dyspnoea) in adults",firstPublishedDate:"Feb 20, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012704.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012704.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012704.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012704.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012704.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012704.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012704.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012704.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012704.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012704.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6485 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012704.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/appendices#CD012704-sec-0086"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/table_n/CD012704StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/table_n/CD012704StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0004">Alison Haywood</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0005">Jacqueline Duc</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0006">Phillip Good</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0007">Sohil Khan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0008">Kirsty Rickett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0009">Petra Vayne-Bossert</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information#CD012704-cr-0010"><i class="icon corresponding-author fa fa-envelope"></i>Janet R Hardy</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information/en#CD012704-sec-0096">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 February 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012704.pub2">https://doi.org/10.1002/14651858.CD012704.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012704-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012704-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012704-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012704-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012704-abs-0001" lang="en"> <section id="CD012704-sec-0001"> <h3 class="title" id="CD012704-sec-0001">Background</h3> <p>Dyspnoea is a common symptom in advanced cancer, with a prevalence of up to 70% among patients at end of life. The cause of dyspnoea is often multifactorial, and may cause considerable psychological distress and suffering. Dyspnoea is often undertreated and good symptom control is less frequently achieved in people with dyspnoea than in people with other symptoms of advanced cancer, such as pain and nausea. The exact mechanism of action of corticosteroids in managing dyspnoea is unclear, yet corticosteroids are commonly used in palliative care for a variety of non‐specific indications, including pain, nausea, anorexia, fatigue and low mood, despite being associated with a wide range of adverse effects. In view of their widespread use, it is important to seek evidence of the effects of corticosteroids for the management of cancer‐related dyspnoea. </p> </section> <section id="CD012704-sec-0002"> <h3 class="title" id="CD012704-sec-0002">Objectives</h3> <p>To assess the effects of systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults. </p> </section> <section id="CD012704-sec-0003"> <h3 class="title" id="CD012704-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, CINAHL, Science Citation Index Web of Science, Latin America and Caribbean Health Sciences (LILACS) and clinical trial registries, from inception to 25 January 2018. </p> </section> <section id="CD012704-sec-0004"> <h3 class="title" id="CD012704-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials that included adults aged 18 years and above. We included participants with cancer‐related dyspnoea when randomised to systemic corticosteroids (at any dose) administered for the relief of cancer‐related dyspnoea or any other indication, compared to placebo, standard or alternative treatment. </p> </section> <section id="CD012704-sec-0005"> <h3 class="title" id="CD012704-sec-0005">Data collection and analysis</h3> <p>Five review authors independently assessed trial quality and three extracted data. We used means and standard deviations for each outcome to report the mean difference (MD) with 95% confidence interval (CI). We assessed the risk of bias and quality of evidence using GRADE. We extracted primary outcomes of sensory‐perceptual experience of dyspnoea (intensity of dyspnoea), affective distress (quality of dyspnoea) and symptom impact (burden of dyspnoea or impact on function) and secondary outcomes of serious adverse events, participant satisfaction with treatment and participant withdrawal from trial. </p> </section> <section id="CD012704-sec-0006"> <h3 class="title" id="CD012704-sec-0006">Main results</h3> <p>Two studies met the inclusion criteria, enrolling 157 participants (37 participants in one study and 120 in the other study), of whom 114 were included in the analyses. The studies compared oral dexamethasone to placebo, followed by an open‐label phase in one study. One study lasted seven days, and the duration of the other study was 15 days. </p> <p>We were unable to conduct many of our predetermined analyses due to different agents, dosages, comparators and outcome measures, routes of drug delivery, measurement scales and time points. Subgroup analysis according to type of cancer was not possible. </p> <p><b>Primary outcomes</b> </p> <p>We included two studies (114 participants) with data at one week in the meta‐analysis for change in dyspnoea intensity/dyspnoea relief from baseline. Corticosteroid therapy with dexamethasone resulted in an MD of lower dyspnoea intensity compared to placebo at one week (MD –0.85 lower dyspnoea (scale 0–10; lower score = less breathlessness), 95% CI ‐1.73 to 0.03; very low‐quality evidence), although we were uncertain as to whether corticosteroids had an important effect on dyspnoea as results were imprecise. We downgraded the quality of evidence by three levels from high to very low due to very serious study limitations and imprecision. </p> <p>One study measured affective distress (quality of dyspnoea) and results were similar between groups (29 participants; very low‐quality evidence). We downgraded the quality of the evidence three times for imprecision, inconsistency, and serious study limitations. </p> <p>Both studies assessed symptom impact (burden of dyspnoea or impact on function) (113 participants; very low‐quality evidence). In one study, it was unclear whether dexamethasone had an effect on dyspnoea as results were imprecise. The second study showed more improvement for physical well‐being scores at days eight and 15 in the dexamethasone group compared with the control group, but there was no evidence of a difference for FACIT social/family, emotional or functional scales. We downgraded the quality of the evidence three times for imprecision, inconsistency, and serious study limitations. </p> <p><b>Secondary outcomes</b> </p> <p>Due to the lack of homogenous outcome measures and inconsistency in reporting, we could not perform quantitative analysis for any secondary outcomes. In both studies, the frequency of adverse events was similar between groups, and corticosteroids were generally well tolerated. The withdrawal rates for the two studies were 15% and 36%. Reasons for withdrawal included lost to follow‐up, participant or carer (or both) refusal, and death due to disease progression. We downgraded the quality of evidence for these secondary outcomes by three levels from high to very low due to serious study limitations, inconsistency and imprecision. </p> <p>Neither study examined participant satisfaction with treatment.</p> </section> <section id="CD012704-sec-0007"> <h3 class="title" id="CD012704-sec-0007">Authors' conclusions</h3> <p>There are few studies assessing the effects of systemic corticosteroids on cancer‐related dyspnoea in adults with cancer. We judged the evidence to be of very low quality that neither supported nor refuted corticosteroid use in this population. Further high‐quality studies are needed to determine if corticosteroids are efficacious in this setting. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012704-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012704-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012704-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012704-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012704-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012704-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012704-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012704-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012704-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012704-abs-0002" lang="en"> <h3>Corticosteroids for the management of cancer‐related breathlessness in adults with cancer </h3> <p><b>Background</b> </p> <p>Breathlessness (dyspnoea) is a common symptom in advanced cancer. Breathlessness may be due to a combination of different causes including lung cancer, metastatic disease elsewhere in the body (for example, cancer in the abdomen pushing up the diaphragm), or cancer‐related conditions affecting the nerves or muscles associated with breathing. Pain and psychological conditions (such as fear and anxiety) or pre‐existing lung disease may make symptoms worse. People with cancer report breathlessness is associated with higher psychological distress and poorer quality of life. Medicines can be used to treat breathlessness in this population, and one common medicine used is corticosteroids. In this review, we evaluated how effective systemic corticosteroids are in treating cancer‐related breathlessness in adults, compared to any control. </p> <p><b>Study characteristics</b> </p> <p>We searched the literature in January 2018. We found two studies, enrolling 157 participants in total, that tested the effect of systemic corticosteroids on breathlessness in adults with cancer, compared to a dummy medicine (placebo). One study lasted seven days, and the other study lasted 15 days. Both studies compared a corticosteroid (oral (by mouth) dexamethasone) to a dummy medicine with no properties to reduce breathlessness, which we included in our analyses. </p> <p>We were interested in the primary outcomes of participant‐reported breathlessness intensity, quality and burden. We were also interested in the secondary outcomes of serious side effects, participant satisfaction with treatment and participant withdrawal from trial. </p> <p><b>Key results</b> </p> <p>We could not complete many of our planned analyses due to the small number of studies, the different medicines and comparisons, and outcomes that the studies reported. We did conduct one analysis of 114 participants to assess change in breathlessness intensity/relief from baseline. We found that corticosteroids had no beneficial effect compared to a dummy medicine on reducing breathlessness intensity in people with cancer. </p> <p>We found that the frequency of side effects was similar between groups, and corticosteroids were generally well tolerated. None of the studies measured participant satisfaction with treatment. Participant withdrawals were 15% and 36% in the two studies. </p> <p><b>Quality of evidence</b> </p> <p>The current evidence was based on only two studies with a small number of participants. We rated the quality of the evidence from these studies using four levels: very low, low, moderate or high. Very low‐quality evidence means that we are very uncertain about the results. High‐quality evidence means that we are very confident in the results. We judged the quality of the evidence in this review to be very low, downgraded due to problems with study quality and too few data. We are very uncertain of the results. More high‐quality studies are needed to determine if corticosteroids are effective for dyspnoea in people with cancer. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012704-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-sec-0074">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-sec-0173">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012704-sec-0074"></div> <h3 class="title" id="CD012704-sec-0075">Implications for practice</h3> <section id="CD012704-sec-0075"> <section id="CD012704-sec-0076"> <h5 class="title">For people with dyspnoea</h5> <p>There is insufficient evidence to support or refute the suggestion that systemic corticosteroids have any efficacy in cancer‐related breathlessness (dyspnoea) in adults. </p> </section> <section id="CD012704-sec-0077"> <h5 class="title">For clinicians</h5> <p>There is insufficient evidence to support or refute the suggestion that systemic corticosteroids have any efficacy in cancer‐related breathlessness (dyspnoea) in adults. This may be particularly relevant when considering the potential toxicity of corticosteroids, especially following prolonged use. </p> </section> <section id="CD012704-sec-0078"> <h5 class="title">For policy makers</h5> <p>There is insufficient evidence to support or refute the suggestion that systemic corticosteroids have any efficacy in cancer‐related breathlessness (dyspnoea) in adults. </p> </section> <section id="CD012704-sec-0079"> <h5 class="title">For funders</h5> <p>There is insufficient evidence to support or refute the suggestion that systemic corticosteroids have any efficacy in cancer‐related breathlessness (dyspnoea) in adults (that is not related to a number of specific respiratory or inflammatory (or both) conditions). </p> </section> </section> <h3 class="title" id="CD012704-sec-0080">Implications for research</h3> <section id="CD012704-sec-0080"> <section id="CD012704-sec-0081"> <h5 class="title">General implications</h5> <p>This review has highlighted a marked paucity of research in the subject area. Future robust, double‐blind randomised trials with significant numbers of participants (e.g. over 200 per treatment arm) are needed to evaluate the safety and effectiveness of systemic corticosteroids in the management of cancer‐related dyspnoea in adults. </p> </section> <section id="CD012704-sec-0082"> <h5 class="title">Design</h5> <p>There are few randomised controlled trials assessing the benefit of systemic corticosteroids in cancer‐related dyspnoea. There is a need for further research to observe the effects of systemic corticosteroids on all three domains of dyspnoea measurement (i.e. dyspnoea intensity, dyspnoea quality and dyspnoea burden/impact on function) alongside participant satisfaction with treatment, and assessment of serious adverse events. Further trials with increased number of participants are needed to evaluate the effectiveness of corticosteroids for the management of dyspnoea in adults with cancer‐related breathlessness. Comparators should include placebo versus combinations of dexamethasone with other antidyspnoea agents, since the mechanism of cancer‐related dyspnoea is not well understood and involves multiple sites of action in the body. </p> </section> <section id="CD012704-sec-0083"> <h5 class="title">Measurement (endpoints)</h5> <p>There is currently no standard outcome measure for the measurement of cancer‐related dyspnoea. This must be determined prior to future studies. Appropriate time points for measuring the effect of corticosteroids on breathlessness also need to be determined. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012704-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012704-sec-0008"></div> <div class="table" id="CD012704-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Systemic corticosteroids compared with placebo for the management of cancer‐related breathlessness (dyspnoea)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Systemic corticosteroids compared with placebo for</b> <b>the management of cancer‐related breathlessness (dyspnoea)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with cancer‐related breathlessness (dyspnoea) </p> <p><b>Settings:</b> inpatients and outpatients </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Breathlessness (dyspnoea) at 1 week (intensity)</b> </p> <p>Scale 0–10;</p> <p>lower score = less breathlessness</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score for intensity of breathlessness at baseline was 4.7 and 3 for the control groups. </p> <p>The mean difference in the intensity of breathlessness at 1 week was –1.3 and –0.58 for the control groups. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score for intensity of breathlessness at baseline was 5.0 and 4.09 for the intervention groups. </p> <p>The mean difference in the intensity of breathlessness at 1 week was –1.8 and –1.56 for the intervention groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Breathlessness (dyspnoea) at 1 week (quality)</b> </p> <p>Cancer Dyspnea Scale</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Small reduction in effort, discomfort and anxiety.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Small reduction in effort and anxiety, with a slight increase in discomfort.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Breathlessness (dyspnoea) at 1 week (burden)</b> </p> <p>EORTC QLQ‐C30, FACIT, ESAS</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Different measurement tools used in each study. Significant reduction in burden at 1 week for dexamethasone group compared to control group observed only for the FACIT physical subscale in one study. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Severity of adverse events was not properly defined making it difficult to assess this outcome. The frequency of adverse events was similar between groups. The intervention was well tolerated in corticosteroid group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>157</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction with treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to GRADE this outcome due to a lack of data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant withdrawal from trial</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>54 withdrawals out of 173 participants (31%) for the two studies. Rate of withdrawal was similar between placebo and dexamethasone groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CI:</b> confidence interval. </p> <p>GRADE Working Group grades of evidence</p> <p><b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect; </p> <p><b>Moderate quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different; </p> <p><b>Low quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect; </p> <p><b>Very low quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded the quality of the evidence once for imprecision due to the small number of participants in the included studies, and twice for very serious study limitations (likely selection and attrition bias). </p> <p><sup>b</sup>Downgraded the quality of the evidence three times: once for imprecision due to the small number of participants in the included study, once for inconsistency, and once for serious study limitations (likely attrition bias). </p> <p><sup>c</sup>Downgraded the quality of the evidence three times: once for imprecision due to the small number of participants in the included studies, once for inconsistency, and once for serious study limitations (likely selection and attrition bias). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012704-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-sec-0009">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-sec-0133">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012704-sec-0009"></div> <section id="CD012704-sec-0010"> <h3 class="title" id="CD012704-sec-0010">Description of the condition</h3> <p>Dyspnoea (breathlessness) is a "subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity" (<a href="./references#CD012704-bbs2-0020" title="American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. American Journal of Respiratory and Critical Care Medicine1999;159(1):321-40.">American Thoracic Society 1999</a>). It is "one of the most common and most feared symptoms amongst cancer patients" (<a href="./references#CD012704-bbs2-0057" title="HuiD , MorgadoM , VidalM , WithersL , NguyenQ , ChisholmG , et al. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. Journal of Palliative Medicine2013;16(3):274-80.">Hui 2013</a>), increases with disease progression (<a href="./references#CD012704-bbs2-0094" title="SolanoJP , GomesB , HigginsonIJ . A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of Pain and Symptom Management2006;31(1):58-69.">Solano 2006</a>), and occurs in up to 70% of people with advanced cancer at end of life (<a href="./references#CD012704-bbs2-0034" title="BrueraE , SchmitzB , PitherJ , NeumannCM , HansonJ . The frequency and correlates of dyspnea in patients with advanced cancer. Journal of Pain and Symptom Management2000;19(5):357-62.">Bruera 2000</a>; <a href="./references#CD012704-bbs2-0041" title="DudgeonDJ , KristjansonL , SloanJA , LertzmanM , ClementK . Dyspnea in cancer patients: prevalence and associated factors. Journal of Pain and Symptom Management2001;21(2):95-102.">Dudgeon 2001</a>; <a href="./references#CD012704-bbs2-0058" title="HuiD , dos SantosR , ChisholmGB , BrueraE . Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. Journal of Pain and Symptom Management2015;50(4):488-94.">Hui 2015</a>; <a href="./references#CD012704-bbs2-0065" title="KutnerJS , KassnerCT , NowelsDE . Symptom burden at the end of life: hospice providers' perceptions. Journal of Pain and Symptom Management2001;21(6):473-80.">Kutner 2001</a>; <a href="./references#CD012704-bbs2-0076" title="MercadanteS , FuscoF , CaruselliA , CartoniC , MaseduF , ValentiM , et al. Background and episodic breathlessness in advanced cancer patients followed at home. Current Medical Research and Opinion2017;33(1):155-60.">Mercadante 2017</a>; <a href="./references#CD012704-bbs2-0097" title="TishelmanC , PeterssonLM , DegnerLF , SprangersMA . Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. Journal of Clinical Oncology2007;25(34):5381-9.">Tishelman 2007</a>; <a href="./references#CD012704-bbs2-0015" title="ViolaR , KiteleyC , Lloyd NS , Mackay JA , WilsonJ , Wong R KS . The management of dyspnea in cancer patients: a systematic review. Supportive Care in Cancer2008;16(4):329-37. ">Viola 2008</a>). Dyspnoea has a negative impact on a patient's quality of life. It interferes with daily life activities (<a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>; <a href="./references#CD012704-bbs2-0076" title="MercadanteS , FuscoF , CaruselliA , CartoniC , MaseduF , ValentiM , et al. Background and episodic breathlessness in advanced cancer patients followed at home. Current Medical Research and Opinion2017;33(1):155-60.">Mercadante 2017</a>; <a href="./references#CD012704-bbs2-0095" title="TanakaK , AkechiT , OkuyamaT , NishiwakiY , UchitomiY . Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. Journal of Pain and Symptom Management2002;23(6):484-9.">Tanaka 2002a</a>), and has been associated with fatigue, anxiety and depression, and decreased function and quality of life, since it may precipitate both physical and psychological distress (<a href="./references#CD012704-bbs2-0024" title="Ben-AharonI , Gafter-GviliA , LeiboviciL , StemmerSM . Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncologica2012;51(8):996-1008.">Ben‐Aharon 2012</a>; <a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>; <a href="./references#CD012704-bbs2-0079" title="MularskiRA , CampbellML , AschSM , ReeveBB , BaschE , MaxwellTL , et al. A review of quality of care evaluation for the palliation of dyspnea. American Journal of Respiratory and Critical Care Medicine2010;181(6):534-8.">Mularski 2010</a>; <a href="./references#CD012704-bbs2-0088" title="SeowH , BarberaL , SutradharR , HowellD , DudgeonD , AtzemaC , et al. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. Journal of Clinical Oncology2011;29(9):1151-8.">Seow 2011</a>; <a href="./references#CD012704-bbs2-0096" title="TanakaK , AkechiT , OkuyamaT , NishiwakiY , UchitomiY . Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else?Journal of Pain and Symptom Management2002;23(6):490-500.">Tanaka 2002b</a>; <a href="./references#CD012704-bbs2-0101" title="WilliamsCM . Dyspnea. Cancer Journal2006;12(5):365-73.">Williams 2006</a>). It may cause significant suffering for patients and their families (<a href="./references#CD012704-bbs2-0025" title="BernhardJ , GanzPA . Psychosocial issues in lung cancer patients (Part 2). Chest1991;99(2):480-5.">Bernhard 1991</a>; <a href="./references#CD012704-bbs2-0028" title="BoothS , MoosaviSH , HigginsonIJ . The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nature Clinical Practice. Oncology2008;5(2):90-100.">Booth 2008</a>), and be a source of substantial healthcare expenditure (<a href="./references#CD012704-bbs2-0026" title="BoothS , SilvesterS , ToddC . Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliative &amp; Supportive Care2003;1(4):337-44.">Booth 2003</a>; <a href="./references#CD012704-bbs2-0031" title="BoothS , FarquharM , SpathisA , BauseweinC , ChinC , PattinsonK . Re: the management of chronic breathlessness: more emphasis on non-pharmacological treatments and the role of the CNS. BMJ2015;349:g7617.">Booth 2015</a>; <a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>; <a href="./references#CD012704-bbs2-0060" title="JohnsonMJ , CurrowDC , BoothS . Prevalence and assessment of breathlessness in the clinical setting. Expert Review of Respiratory Medicine2014;8(2):151-61.">Johnson 2014</a>; <a href="./references#CD012704-bbs2-0087" title="SeamarkDA , BlakeSD , SeamarkCJ , HalpinDM . Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliative Medicine2004;18(7):619-25.">Seamark 2004</a>; <a href="./references#CD012704-bbs2-0091" title="SkaugK , EideGE , GulsvikA . Hospitalisation days in patients with lung cancer in a general population. Respiratory Medicine2009;103(12):1941-8.">Skaug 2009</a>). It is frightening for many patients who report feeling that they are suffocating, choking (<a href="./references#CD012704-bbs2-0092" title="SkevingtonSM , PilaarM , RouthD , MacleodRD . On the language of breathlessness. Psychology and Health1997;12(5):677-89.">Skevington 1997</a>), short of breath, unable to get a breath or drowning (<a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>; <a href="./references#CD012704-bbs2-0063" title="KlokeM , ChernyN , ESMO Guidelines Committee. Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology2015;26(Suppl 5):v169-73.">Kloke 2015</a>; <a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>; <a href="./references#CD012704-bbs2-0100" title="WilcockA , CrosbyV , HughesA , FieldingK , CorcoranR , TattersfieldAE . Descriptors of breathlessness in patients with cancer and other cardiorespiratory diseases. Journal of Pain and Symptom Management2002;23(3):182-9.">Wilcock 2002</a>). </p> <p>Good symptom control is less frequently achieved in people with dyspnoea than in people with other symptoms of advanced cancer, such as pain and nausea (<a href="./references#CD012704-bbs2-0104" title="YennurajalingamS , BrueraE . Cancer Management Handbook. Fatigue and Dyspnea. Cancer Network2015. [www.cancernetwork.com/cancer-management/fatigue-and-dyspnea]">Yennurajalingam 2015</a>). When disease is advanced, patients may experience episodes of acute breathlessness (<a href="./references#CD012704-bbs2-0076" title="MercadanteS , FuscoF , CaruselliA , CartoniC , MaseduF , ValentiM , et al. Background and episodic breathlessness in advanced cancer patients followed at home. Current Medical Research and Opinion2017;33(1):155-60.">Mercadante 2017</a>), "superimposed on a background level of continuous breathlessness" (<a href="./references#CD012704-bbs2-0061" title="JohnsonMJ , HuiD , CurrowDC . Opioids, exertion, and dyspnea: a review of the evidence. American Journal of Hospice &amp; Palliative Care2016;33(2):194-200.">Johnson 2016</a>). Episodes of breathlessness may be predictable (generally caused by physical exertion) or unpredictable (<a href="./references#CD012704-bbs2-0061" title="JohnsonMJ , HuiD , CurrowDC . Opioids, exertion, and dyspnea: a review of the evidence. American Journal of Hospice &amp; Palliative Care2016;33(2):194-200.">Johnson 2016</a>; <a href="./references#CD012704-bbs2-0090" title="SimonPM , SchwartzsteinRM , WeissJW , FenclV , TeghtsoonianM , WeinbergerSE . Distinguishable types of dyspnea in patients with shortness of breath. American Review of Respiratory Disease1990;142(5):1009-14.">Simon 1990</a>). </p> <p>The pathophysiology of dyspnoea is complex and is not fully understood (<a href="./references#CD012704-bbs2-0028" title="BoothS , MoosaviSH , HigginsonIJ . The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nature Clinical Practice. Oncology2008;5(2):90-100.">Booth 2008</a>; <a href="./references#CD012704-bbs2-0035" title="BurkiNK , LeeLY . Mechanisms of dyspnea. Chest2010;138(5):1196-201.">Burki 2010</a>; <a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>; <a href="./references#CD012704-bbs2-0057" title="HuiD , MorgadoM , VidalM , WithersL , NguyenQ , ChisholmG , et al. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. Journal of Palliative Medicine2013;16(3):274-80.">Hui 2013</a>; <a href="./references#CD012704-bbs2-0073" title="ManningHL , SchwartzsteinRM . Pathophysiology of dyspnea. New England Journal of Medicine1995;333(23):1547-53.">Manning 1995</a>; <a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>). A constellation of sensory inputs may contribute to the multiple sensations of dyspnoea, which may include the "sensations of work or effort, tightness, and air hunger/unsatisfied inspiration" (<a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>). Tightness is relatively specific to stimulation of airway receptors in conjunction with bronchoconstriction, while intensity of air hunger/unsatisfied inspiration is magnified by imbalances among inspiratory drive, efferent activation (outgoing motor command from the brain), and feedback from afferent receptors throughout the respiratory system (<a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>). In the palliative care setting, the cause of dyspnoea is often multifactorial (<a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>), with an unpredictable response to treatment (<a href="./references#CD012704-bbs2-0070" title="LinRJ , AdelmanRD , MehtaSS . Dyspnea in palliative care: expanding the role of corticosteroids. Journal of Palliative Medicine2012;15(7):834-7.">Lin 2012</a>). Indeed, the subjective experience of dyspnoea is influenced by "multiple physical, psychological, social and spiritual factors, and may induce secondary physiological and behavioral responses" (<a href="./references#CD012704-bbs2-0071" title="LokCW . Management of breathlessness in patients with advanced cancer: a narrative review. American Journal of Hospice &amp; Palliative Care2016;33(3):286-90.">Lok 2016</a>). The concept of 'total dyspnoea' – similar to that of 'total pain' – may provide a framework in the multidimensional assessment and management of breathlessness (<a href="./references#CD012704-bbs2-0019" title="AbernethyAP , WheelerJL . Total dyspnoea. Current Opinion in Supportive and Palliative Care2008;2(2):110-3.">Abernethy 2008</a>; <a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>), as each of these factors may contribute to the perceived severity of a person's dyspnoea (<a href="./references#CD012704-bbs2-0021" title="BanzettRB , PedersenSH , SchwartzsteinRM , LansingRW . The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. American Journal of Respiratory and Critical Care Medicine2008;177(12):1384-90.">Banzett 2008</a>; <a href="./references#CD012704-bbs2-0037" title="ChinC , BoothS . Managing breathlessness: a palliative care approach. Postgraduate Medical Journal2016;92(1089):393-400.">Chin 2016</a>; <a href="./references#CD012704-bbs2-0039" title="De PeuterS , Van DiestI , LemaigreV , VerledenG , DemedtsM , Van den BerghO . Dyspnea: the role of psychological processes. Clinical Psychology Review2004;24(5):557-81.">De Peuter 2004</a>; <a href="./references#CD012704-bbs2-0044" title="EvansKC , BanzettRB , AdamsL , McKayL , FrackowiakRS , CorfieldDR . BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. Journal of Neurophysiology2002;88(3):1500-11.">Evans 2002</a>; <a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>). </p> <p>Common pulmonary causes of dyspnoea in cancer may include progressive metastatic disease, lymphangitis carcinomatosa, pleuritis carcinomatosa, pleural effusion, interstitial lung disease, parenchymal lung involvement, pulmonary embolism, infection, atelectasis, airway obstruction and pre‐existing pulmonary disease (<a href="./references#CD012704-bbs2-0030" title="BoothS , BurkinJ , MoffatC , SpathisA . Managing Breathlessness in Clinical Practice. Berlin: Springer, 2014.">Booth 2014</a>; <a href="./references#CD012704-bbs2-0036" title="ChanKS , ShamMM , TseDM , ThorsenAB . Palliative medicine in malignant respiratory diseases. In: DoyleD , HanksG , CherneyN , editors(s). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 2004:1107-44.">Chan 2004</a>; <a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>; <a href="./references#CD012704-bbs2-0066" title="KvalePA , SeleckyPA , PrakashUB . Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest2007;132(3 Suppl):368s-403s.">Kvale 2007</a>; <a href="./references#CD012704-bbs2-0073" title="ManningHL , SchwartzsteinRM . Pathophysiology of dyspnea. New England Journal of Medicine1995;333(23):1547-53.">Manning 1995</a>). Systemic causes of dyspnoea may include anaemia, hypoxaemia, uraemia or acidaemia, congestive cardiac failure, pericarditis or pericardial effusion, pulmonary hypertension, sepsis, cardiovascular/physical deconditioning, muscle weakness or neuromuscular conditions (<a href="./references#CD012704-bbs2-0030" title="BoothS , BurkinJ , MoffatC , SpathisA . Managing Breathlessness in Clinical Practice. Berlin: Springer, 2014.">Booth 2014</a>; <a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>). Other common causes include pain, ascites, hepatomegaly, obesity, lymphadenopathy, superior vena cava obstruction, treatment‐related adverse effects (e.g. pneumonitis or fibrosis following chemotherapy or radiotherapy) and pre‐existing lung disease (e.g. asthma or chronic obstructive pulmonary disease (COPD)). Psychological drivers or psychogenic causes, such as panic disorder, anxiety and distress, may also contribute to the genesis of breathlessness or further compound symptoms, or both (<a href="./references#CD012704-bbs2-0049" title="GiardinoND , CurtisJL , AbelsonJL , KingAP , PampB , LiberzonI , et al. The impact of panic disorder on interoception and dyspnea reports in chronic obstructive pulmonary disease. Biological Psychology2010;84(1):142-6.">Giardino 2010</a>; <a href="./references#CD012704-bbs2-0064" title="KunikME , RoundyK , VeazeyC , SouchekJ , RichardsonP , WrayNP , et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest2005;127(4):1205-11.">Kunik 2005</a>; <a href="./references#CD012704-bbs2-0078" title="MooreMC , ZebbBJ . The catastrophic misinterpretation of physiological distress. Behaviour Research and Therapy1999;37(11):1105-18.">Moore 1999</a>; <a href="./references#CD012704-bbs2-0080" title="NardiAE , FreireRC , ZinWA . Panic disorder and control of breathing. Respiratory Physiology &amp; Neurobiology2009;167(1):133-43.">Nardi 2009</a>; <a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>; <a href="./references#CD012704-bbs2-0083" title="PernaG , CaldirolaD , NamiaC , CucchiM , VanniG , BellodiL . Language of dyspnea in panic disorder. Depression and Anxiety2004;20(1):32-8.">Perna 2004</a>; <a href="./references#CD012704-bbs2-0084" title="RassovskyY , AbramsK , KushnerMG . Suffocation and respiratory responses to carbon dioxide and breath holding challenges in individuals with panic disorder. Journal of Psychosomatic Research2006;60(3):291-8.">Rassovsky 2006</a>; <a href="./references#CD012704-bbs2-0093" title="SmollerJW , PollackMH , OttoMW , RosenbaumJF , KradinRL . Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. American Journal of Respiratory and Critical Care Medicine1996;154(1):6-17.">Smoller 1996</a>; <a href="./references#CD012704-bbs2-0102" title="WilliamsM , CafarellaP , OldsT , PetkovJ , FrithP . Affective descriptors of the sensation of breathlessness are more highly associated with severity of impairment than physical descriptors in people with COPD. Chest2010;138(2):315-22.">Williams 2010</a>). The symptoms of dyspnoea are usually managed following careful assessment of the potential cause and impact on the person's experience, and treatment of any reversible causes (<a href="./references#CD012704-bbs2-0037" title="ChinC , BoothS . Managing breathlessness: a palliative care approach. Postgraduate Medical Journal2016;92(1089):393-400.">Chin 2016</a>; <a href="./references#CD012704-bbs2-0073" title="ManningHL , SchwartzsteinRM . Pathophysiology of dyspnea. New England Journal of Medicine1995;333(23):1547-53.">Manning 1995</a>). Dyspnoea that appears suddenly is more likely to be reversible than progressive longstanding dyspnoea that is related to disease progression as it is likely to be related to a treatable acute event such as infection or pulmonary embolism (<a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>). Therefore, it is important to consider assessment for potentially reversible causes of dyspnoea (<a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>). As the sensation of dyspnoea is mediated by the central nervous system (<a href="./references#CD012704-bbs2-0054" title="HerigstadM , HayenA , WiechK , PattinsonKT . Dyspnoea and the brain. Respiratory Medicine2011;105(6):809-17.">Herigstad 2011</a>), strategies that address psychosocial stressors or psychological triggers are also key, to "reduce the impact of the sensation of breathlessness, even when it cannot be removed" (<a href="./references#CD012704-bbs2-0031" title="BoothS , FarquharM , SpathisA , BauseweinC , ChinC , PattinsonK . Re: the management of chronic breathlessness: more emphasis on non-pharmacological treatments and the role of the CNS. BMJ2015;349:g7617.">Booth 2015</a>). Therefore, non‐pharmacological techniques are of central importance in the management of breathlessness (<a href="./references#CD012704-bbs2-0031" title="BoothS , FarquharM , SpathisA , BauseweinC , ChinC , PattinsonK . Re: the management of chronic breathlessness: more emphasis on non-pharmacological treatments and the role of the CNS. BMJ2015;349:g7617.">Booth 2015</a>; <a href="./references#CD012704-bbs2-0047" title="FarquharMC , PrevostAT , McCroneP , Brafman-PriceB , BentleyA , HigginsonIJ , et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Medicine2014;12:194.">Farquhar 2014</a>), and active management of psychosocial issues such as anxiety, depression, carer stress and distress, and the implementation of non‐pharmacological self‐management strategies such as physical and mental activity, relaxation techniques, breathing exercises, education and information should be a priority (<a href="./references#CD012704-bbs2-0031" title="BoothS , FarquharM , SpathisA , BauseweinC , ChinC , PattinsonK . Re: the management of chronic breathlessness: more emphasis on non-pharmacological treatments and the role of the CNS. BMJ2015;349:g7617.">Booth 2015</a>). Modification of the patient's environment, activity pacing and energy conservation (<a href="./references#CD012704-bbs2-0086" title="SackleyCM , vanden BergME , LettK , PatelS , HollandsK , WrightCC , et al. Effects of a physiotherapy and occupational therapy intervention on mobility and activity in care home residents: a cluster randomised controlled trial. BMJ2009;339:b3123.">Sackley 2009</a>), and anxiety reduction training (<a href="./references#CD012704-bbs2-0067" title="LaiWS , ChaoCS , YangWP , ChenCH . Efficacy of guided imagery with theta music for advanced cancer patients with dyspnea: a pilot study. Biological Research for Nursing2010;12(2):188-97.">Lai 2010</a>), may also maximise comfort, improve respiratory efficiency, and reduce fear and anxiety (<a href="./references#CD012704-bbs2-0039" title="De PeuterS , Van DiestI , LemaigreV , VerledenG , DemedtsM , Van den BerghO . Dyspnea: the role of psychological processes. Clinical Psychology Review2004;24(5):557-81.">De Peuter 2004</a>; <a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>; <a href="./references#CD012704-bbs2-0047" title="FarquharMC , PrevostAT , McCroneP , Brafman-PriceB , BentleyA , HigginsonIJ , et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Medicine2014;12:194.">Farquhar 2014</a>; <a href="./references#CD012704-bbs2-0056" title="HigginsonIJ , BauseweinC , ReillyCC , GaoW , GyselsM , DzinginaM , et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respiratory Medicine2014;2(12):979-87.">Higginson 2014</a>; <a href="./references#CD012704-bbs2-0062" title="KamalAH , MaguireJM , WheelerJL , CurrowDC , AbernethyAP . Dyspnea review for the palliative care professional: treatment goals and therapeutic options. Journal of Palliative Medicine2012;15(1):106-14.">Kamal 2012</a>). For example, the use of a fan is one of the most important and effective non‐pharmacological interventions in the management and relief of breathlessness (<a href="./references#CD012704-bbs2-0023" title="BauseweinC , BoothS , GyselsM , HigginsonI . Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database of Systematic Reviews2008, Issue 2. Art. No: CD005623. [DOI: 10.1002/14651858.CD005623.pub2]">Bausewein 2008</a>; <a href="./references#CD012704-bbs2-0048" title="GalbraithS , FaganP , PerkinsP , LynchA , BoothS . Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. Journal of Pain and Symptom Management2010;39(5):831-8.">Galbraith 2010</a>). Johnson and colleagues postulated that "as skeletal muscle (not limited to the muscles of respiration) is intimately involved in the genesis of breathlessness, reduced activity leads to reduced muscle bulk so that over time, breathlessness will be triggered by less and less exertion breathlessness" (<a href="./references#CD012704-bbs2-0060" title="JohnsonMJ , CurrowDC , BoothS . Prevalence and assessment of breathlessness in the clinical setting. Expert Review of Respiratory Medicine2014;8(2):151-61.">Johnson 2014</a>). Exercise‐based rehabilitation, a complex intervention that incorporates cognitive and behavioural management strategies (<a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>), pulmonary rehabilitation, and other integrated, complex intervention services for breathlessness may thus be of use or benefit for people with dyspnoea (<a href="./references#CD012704-bbs2-0027" title="BoothS , FarquharM , GyselsM , BauseweinC , HigginsonIJ . The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliative &amp; Supportive Care2006;4(3):287-93.">Booth 2006</a>; <a href="./references#CD012704-bbs2-0029" title="BoothS , MoffatC , FarquharM , HigginsonIJ , BurkinJ . Developing a breathlessness intervention service for patients with palliative and supportive care needs, irrespective of diagnosis. Journal of Palliative Care2011;27(1):28-36.">Booth 2011</a>; <a href="./references#CD012704-bbs2-0046" title="FarquharM , HigginsonIJ , FaganP , BoothS . Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report. Palliative and Supportive Care2010;8(2):143-9.">Farquhar 2010</a>; <a href="./references#CD012704-bbs2-0047" title="FarquharMC , PrevostAT , McCroneP , Brafman-PriceB , BentleyA , HigginsonIJ , et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Medicine2014;12:194.">Farquhar 2014</a>). From an anxiety reduction training point of view, cognitive behavioural therapy, simple relaxation therapy, distraction methods, music or mindfulness may also help people feel more control (<a href="./references#CD012704-bbs2-0071" title="LokCW . Management of breathlessness in patients with advanced cancer: a narrative review. American Journal of Hospice &amp; Palliative Care2016;33(3):286-90.">Lok 2016</a>), and 'gain mastery' over their breathlessness (<a href="./references#CD012704-bbs2-0030" title="BoothS , BurkinJ , MoffatC , SpathisA . Managing Breathlessness in Clinical Practice. Berlin: Springer, 2014.">Booth 2014</a>). For severe, chronic, refractory or intractable dyspnoea, non‐pharmacological methods may be supplemented by pharmacological treatments. These may include oral or parenteral opioids (<a href="./references#CD012704-bbs2-0024" title="Ben-AharonI , Gafter-GviliA , LeiboviciL , StemmerSM . Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncologica2012;51(8):996-1008.">Ben‐Aharon 2012</a>; <a href="./references#CD012704-bbs2-0060" title="JohnsonMJ , CurrowDC , BoothS . Prevalence and assessment of breathlessness in the clinical setting. Expert Review of Respiratory Medicine2014;8(2):151-61.">Johnson 2014</a>; <a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>; <a href="./references#CD012704-bbs2-0015" title="ViolaR , KiteleyC , Lloyd NS , Mackay JA , WilsonJ , Wong R KS . The management of dyspnea in cancer patients: a systematic review. Supportive Care in Cancer2008;16(4):329-37. ">Viola 2008</a>), benzodiazepines (if the person is experiencing significant anxiety), alongside other non‐pharmacological strategies (<a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>), oxygen (if a person is hypoxic) (<a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>), and steroids (<a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>; <a href="./references#CD012704-bbs2-0062" title="KamalAH , MaguireJM , WheelerJL , CurrowDC , AbernethyAP . Dyspnea review for the palliative care professional: treatment goals and therapeutic options. Journal of Palliative Medicine2012;15(1):106-14.">Kamal 2012</a>). Systemic corticosteroids are also commonly used for specific antitumour effect in conditions such as lymphangitis carcinomatosa or airway obstruction by tumour (<a href="./references#CD012704-bbs2-0005" title="ElsayemA , BrueraE . High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway. Supportive Care in Cancer2007;15(12):1437-9. ">Elsayem 2007</a>). </p> </section> <section id="CD012704-sec-0011"> <h3 class="title" id="CD012704-sec-0011">Description of the intervention</h3> <p>Systemic corticosteroids are commonly used in palliative care practice for symptom control of fatigue (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>), nausea and vomiting (<a href="./references#CD012704-bbs2-0098" title="Vayne-BossertP , HaywoodA , GoodP , KhanS , RickettK , HardyJR . Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). Cochrane Database of Systematic Reviews2017, Issue 7. Art. No: CD012002. [DOI: 10.1002/14651858.CD012002.pub2]">Vayne‐Bossert 2017</a>), anorexia, cachexia and pain, relief of spinal cord compression, reduction of vasogenic oedema from brain metastasis and resolution from malignant bowel obstruction (<a href="./references#CD012704-bbs2-0052" title="HardyJR , ReesE , LingJ , BurmanR , FeuerD , BroadleyK , et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliative Medicine2001;15(1):3-8.">Hardy 2001</a>; <a href="./references#CD012704-bbs2-0070" title="LinRJ , AdelmanRD , MehtaSS . Dyspnea in palliative care: expanding the role of corticosteroids. Journal of Palliative Medicine2012;15(7):834-7.">Lin 2012</a>; <a href="./references#CD012704-bbs2-0075" title="MercadanteS , FulfaroF , CasuccioA . The use of corticosteroids in home palliative care. Supportive Care in Cancer2001;9(5):386-9.">Mercadante 2001</a>; <a href="./references#CD012704-bbs2-0082" title="PaulsenO , KlepstadP , RoslandJH , AassN , AlbertE , FayersP , et al. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. Journal of Clinical Oncology2014;32(29):3221-8.">Paulsen 2014</a>; <a href="./references#CD012704-bbs2-0089" title="ShihA , Jackson KC 2nd. Role of corticosteroids in palliative care. Journal of Pain and Palliative Care Pharmacotherapy2007;21(4):69-76.">Shih 2007</a>). The corticosteroid used most commonly in palliative care is dexamethasone, due to its potency, long duration of action allowing once‐daily dosing and the ability to administer it subcutaneously (<a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>). The balance of benefit versus risk of harm must be carefully considered. Adverse effects are usually dose and duration related, and include insomnia, mental disturbances (including depression, mania, psychosis or delirium), hyperglycaemia, increased susceptibility to infection, gastric irritation, Cushingoid features and proximal myopathy (<a href="./references#CD012704-bbs2-0043" title="Palliative Care Expert Group. Therapeutic Guidelines: Palliative Care, version 4. Melbourne: Therapeutic Guidelines Limited, 2016.">eTG 2016</a>). </p> </section> <section id="CD012704-sec-0012"> <h3 class="title" id="CD012704-sec-0012">How the intervention might work</h3> <p>Dyspnoea, or the sensation of breathlessness, is closely related to the sensation of respiratory effort experienced via the activation of proprioceptive pathways during respiration (<a href="./references#CD012704-bbs2-0040" title="DormanS , JolleyC , AbernethyA , CurrowD , JohnsonM , FarquharM , et al. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliative Medicine2009;23(3):213-27.">Dorman 2009</a>). While the respiratory centre in the medulla controls breathing, dyspnoea is the result of cortical stimulation (<a href="./references#CD012704-bbs2-0040" title="DormanS , JolleyC , AbernethyA , CurrowD , JohnsonM , FarquharM , et al. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliative Medicine2009;23(3):213-27.">Dorman 2009</a>; <a href="./references#CD012704-bbs2-0057" title="HuiD , MorgadoM , VidalM , WithersL , NguyenQ , ChisholmG , et al. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. Journal of Palliative Medicine2013;16(3):274-80.">Hui 2013</a>). Both lung and central chemoreceptors detect abnormalities in blood gases (hypoxia, increased partial pressure of carbon dioxide), and together with lung and respiratory muscle mechanoreceptors (responding to stretching and pulmonary irritants), stimulate the medullary respiratory centre. The activity of the chemoreceptors, mechanoreceptors and respiratory centre can also stimulate the cerebral cortex, thus directly contributing to the sensation of dyspnoea (<a href="./references#CD012704-bbs2-0040" title="DormanS , JolleyC , AbernethyA , CurrowD , JohnsonM , FarquharM , et al. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliative Medicine2009;23(3):213-27.">Dorman 2009</a>; <a href="./references#CD012704-bbs2-0057" title="HuiD , MorgadoM , VidalM , WithersL , NguyenQ , ChisholmG , et al. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. Journal of Palliative Medicine2013;16(3):274-80.">Hui 2013</a>). Cancer, in a similar manner to COPD, is characterised by a significant inflammatory component that includes airway wall infiltration of macrophages and T lymphocytes, increased lung tumour necrosis factor‐alpha and interleukin (IL)‐8, elevated serum IL‐6, C‐reactive protein, increased peripheral neutrophil activation (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>), and inflammatory cytokines (<a href="./references#CD012704-bbs2-0099" title="WangXS , ShiQ , WilliamsLA , MaoL , CleelandCS , KomakiRR , et al. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain, Behavior, and Immunity2010;24(6):968-74.">Wang 2010</a>). Corticosteroids have potent anti‐inflammatory activity that may explain their ability to alleviate dyspnoea, as people with advanced cancer often have an elevated inflammatory response that can contribute to dyspnoea both peripherally and centrally (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). The usefulness of the anti‐inflammatory activity of corticosteroids in managing acute exacerbations of COPD is well established (<a href="./references#CD012704-bbs2-0022" title="BarczykA , SozanskaE , TrzaskaM , PierzchalaW . Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. Chest2004;126(2):389-93.">Barczyk 2004</a>; <a href="./references#CD012704-bbs2-0033" title="BrightlingCE , MonteiroW , WardR , ParkerD , MorganMD , WardlawAJ , et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet2000;356(9240):1480-5.">Brightling 2000</a>; <a href="./references#CD012704-bbs2-0038" title="CulpittSV , RogersDF , ShahP , De MatosC , RussellRE , DonnellyLE , et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2003;167(1):24-31.">Culpitt 2003</a>; <a href="./references#CD012704-bbs2-0045" title="FalkJA , MinaiOA , MosenifarZ . Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society2008;5(4):506-12.">Falk 2008</a>; <a href="./references#CD012704-bbs2-0103" title="Wood-BakerRR , GibsonPG , HannayM , WaltersEH , WaltersJA . Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews2005, Issue 1. Art. No: CD001288. [DOI: 10.1002/14651858.CD001288.pub4]">Wood‐Baker 2005</a>). However, as dyspnoea is likely to be multifactorial in the context of cancer, corticosteroids may work more effectively in some instances (e.g. where there is a process of inflammation), but not as well in other instances. </p> </section> <section id="CD012704-sec-0013"> <h3 class="title" id="CD012704-sec-0013">Why it is important to do this review</h3> <p>Dyspnoea is a common and devastating symptom in people with cancer that often worsens in the last months of life and may be difficult to treat (<a href="./references#CD012704-bbs2-0041" title="DudgeonDJ , KristjansonL , SloanJA , LertzmanM , ClementK . Dyspnea in cancer patients: prevalence and associated factors. Journal of Pain and Symptom Management2001;21(2):95-102.">Dudgeon 2001</a>; <a href="./references#CD012704-bbs2-0058" title="HuiD , dos SantosR , ChisholmGB , BrueraE . Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. Journal of Pain and Symptom Management2015;50(4):488-94.">Hui 2015</a>; <a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0076" title="MercadanteS , FuscoF , CaruselliA , CartoniC , MaseduF , ValentiM , et al. Background and episodic breathlessness in advanced cancer patients followed at home. Current Medical Research and Opinion2017;33(1):155-60.">Mercadante 2017</a>; <a href="./references#CD012704-bbs2-0097" title="TishelmanC , PeterssonLM , DegnerLF , SprangersMA . Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. Journal of Clinical Oncology2007;25(34):5381-9.">Tishelman 2007</a>). Systemic corticosteroids are commonly used in palliative care, particularly for people with advanced malignant disease, for a variety of symptom control indications including pain, nausea, vomiting, anorexia, fatigue and dyspnoea (<a href="./references#CD012704-bbs2-0070" title="LinRJ , AdelmanRD , MehtaSS . Dyspnea in palliative care: expanding the role of corticosteroids. Journal of Palliative Medicine2012;15(7):834-7.">Lin 2012</a>; <a href="./references#CD012704-bbs2-0089" title="ShihA , Jackson KC 2nd. Role of corticosteroids in palliative care. Journal of Pain and Palliative Care Pharmacotherapy2007;21(4):69-76.">Shih 2007</a>), despite the fact that steroids may be associated with significant adverse effects (<a href="./references#CD012704-bbs2-0074" title="MatsuoN , MoritaT , IwaseS . Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. Journal of Palliative Medicine2011;14(7):840-5.">Matsuo 2011</a>), especially following long‐term use. However, there is little objective evidence in the literature to support the use of systemic corticosteroids for symptom control (<a href="./references#CD012704-bbs2-0042" title="BauseweinC , CurrowC , JohnsonMJ . Palliative Care in Respiratory Disease: ERS Monograph 73. Sheffield (UK): European Respiratory Society, 2016.">ERS Monograph 2016</a>; <a href="./references#CD012704-bbs2-0015" title="ViolaR , KiteleyC , Lloyd NS , Mackay JA , WilsonJ , Wong R KS . The management of dyspnea in cancer patients: a systematic review. Supportive Care in Cancer2008;16(4):329-37. ">Viola 2008</a>), and concerns have been raised about the 'uncontrolled' use of steroids in people with cancer (<a href="./references#CD012704-bbs2-0053" title="HaywoodA , GoodP , KhanS , LeuppA , Jenkins-MarshS , RickettK , et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD010756. [DOI: 10.1002/14651858.CD010756.pub2]">Haywood 2015</a>; <a href="./references#CD012704-bbs2-0069" title="LevyM , SmithT , Alvarez-PerezA , BackA , BakerJN , BeckAC , et al. Palliative Care Version 1. Journal of the National Comprehensive Cancer Network : JNCCN2016;14(1):82-113.">Levy 2016</a>; <a href="./references#CD012704-bbs2-0098" title="Vayne-BossertP , HaywoodA , GoodP , KhanS , RickettK , HardyJR . Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). Cochrane Database of Systematic Reviews2017, Issue 7. Art. No: CD012002. [DOI: 10.1002/14651858.CD012002.pub2]">Vayne‐Bossert 2017</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012704-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-sec-0014">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-sec-0138">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012704-sec-0014"></div> <p>To assess the effects of systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012704-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-sec-0015">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-sec-0139">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012704-sec-0015"></div> <section id="CD012704-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012704-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised double‐blind controlled trials (RCTs) with full journal publication, as well as online clinical trial results and summaries of otherwise unpublished clinical trials or abstracts with sufficient data for analysis. We excluded studies that were non‐randomised, case reports and clinical observations, and short abstracts (usually meeting reports). </p> </section> <section id="CD012704-sec-0018"> <h4 class="title">Types of participants</h4> <p>Participants with cancer with cancer‐related dyspnoea, aged 18 years and above.</p> </section> <section id="CD012704-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Systemic corticosteroids at any dose, administered for the relief of cancer‐related dyspnoea or other cancer‐related symptoms (where dyspnoea was also measured), compared to placebo or any active comparator including supportive care or alternate non‐pharmacological treatment. We excluded studies assessing inhaled corticosteroids. </p> </section> <section id="CD012704-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD012704-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012704-list-0001"> <li> <p>Our primary outcome was the effect of systemic corticosteroids on breathlessness (dyspnoea), as assessed by the American Thoracic Society 'Domains of Dyspnoea Measurement' (<a href="./references#CD012704-bbs2-0081" title="ParshallMB , SchwartzsteinRM , AdamsL , BanzettRB , ManningHL , BourbeauJ , et al, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine2012;185(4):435-52.">Parshall 2012</a>). </p> </li> </ul> </p> <section id="CD012704-sec-0022"> <h6 class="title">Domain 1: Sensory‐perceptual experience – intensity of dyspnoea</h6> <p>Definition: measures of what breathing feels like to the patient or research subject. Examples include: </p> <p> <ul id="CD012704-list-0002"> <li> <p>single‐item ratings of intensity such as the Borg scale (<a href="./references#CD012704-bbs2-0032" title="BorgGA . Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise1982;14(5):377-81.">Borg 1982</a>), Visual Analogue Scale (VAS) (<a href="./references#CD012704-bbs2-0050" title="GiftAG . Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabilitation Nursing1989;14(6):323-5.">Gift 1989</a>). </p> </li> </ul> </p> </section> <section id="CD012704-sec-0023"> <h6 class="title">Domain 2: Affective distress – quality of dyspnoea</h6> <p>Definition: measures of how distressing breathing feels. Focus can be either immediate (e.g. unpleasantness) or evaluative (e.g. judgements of meaning or consequence). Examples include: </p> <p> <ul id="CD012704-list-0003"> <li> <p>single‐item ratings of severity of distress or unpleasantness; and</p> </li> <li> <p>multi‐item scales of emotional responses such as anxiety such as the Hospital Anxiety and Depression Scale (HADS), or State‐Trait Anxiety Inventory (STAI). </p> </li> </ul> </p> </section> <section id="CD012704-sec-0024"> <h6 class="title">Domain 3: Symptom impact‐burden of dyspnoea/impact on function</h6> <p>Definition: measures of how dyspnoea affects functional ability, employment (disability), quality of life or health status. Examples include: </p> <p> <ul id="CD012704-list-0004"> <li> <p>unidimensional rating of disability or activity limitation such as the Medical Research Council (MRC) Dyspnoea Scale (<a href="./references#CD012704-bbs2-0072" title="MahlerDA , WellsCK . Evaluation of clinical methods for rating dyspnea. Chest1988;93(3):580-6.">Mahler 1988</a>); </p> </li> <li> <p>unidimensional or multidimensional ratings of functional ability (Pulmonary Functional Status and Dyspnoea Questionnaire (PFSDQ) (<a href="./references#CD012704-bbs2-0068" title="LareauSC , MeekPM , RoosPJ . Development and testing of the modified version of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ-M). Heart &amp; Lung1998;27(3):159-68.">Lareau 1998</a>); and </p> </li> <li> <p>multidimensional scales of quality of life/health status.</p> </li> </ul> </p> <p>We aimed to use both standardised, mean pre–post change in breathlessness scores after the intervention (comparator), as well as post‐intervention standardised mean difference (SMD) in breathlessness scores between intervention and comparator groups. We aimed to also summarise breathlessness outcomes separately, to delineate between breathlessness measured 'now' versus 'on average over the past 24 hours' or as described by the validated outcome measure. </p> <p>We aimed to obtain standardised means when seeking to summarise and compare studies that use different breathlessness measures (regardless of the scoring system). </p> </section> </section> <section id="CD012704-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012704-list-0005"> <li> <p>Serious adverse events – any untoward medical occurrence that at any dose resulted in death, was life‐threatening, required inpatient hospitalisation or prolongation of existing hospitalisation, resulted in persistent or significant disability/incapacity or was a congenital anomaly/birth defect (<a href="./references#CD012704-bbs2-0059" title="ICH Expert Working Group. ICH Harmonised Tripartite Guideline. Clinical safety data management: definitions and standards for expedited reporting E2A. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf (accessed 21 June 2017).">ICH 1994</a>). </p> </li> <li> <p>Participant satisfaction with treatment.</p> </li> <li> <p>Participant withdrawal.</p> </li> </ul> </p> </section> </section> </section> <section id="CD012704-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <p>We attempted to identify as many trials as possible that met the inclusion criteria with our search strategy, without limitation by language, publication type, status or date. </p> <section id="CD012704-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases without language restrictions.</p> <p> <ul id="CD012704-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) 2018, Issue 1 in the Cochrane Library (<a href="./appendices#CD012704-sec-0087">Appendix 1</a>); </p> </li> <li> <p>MEDLINE (Ovid) 1966 to 25 January 2018 (<a href="./appendices#CD012704-sec-0088">Appendix 2</a>); </p> </li> <li> <p>Embase.com 1970 to 25 January 2018 (<a href="./appendices#CD012704-sec-0089">Appendix 3</a>); </p> </li> <li> <p>CINAHL (EBSCO) 1982 to 25 January 2018 (<a href="./appendices#CD012704-sec-0090">Appendix 4</a>); </p> </li> <li> <p>Science Citation Index (ISI Web of Science) 1899 to 25 January 2018 (<a href="./appendices#CD012704-sec-0091">Appendix 5</a>); </p> </li> <li> <p>Latin America and Caribbean Health Sciences (LILACS) 1982 to 25 January 2018 (<a href="./appendices#CD012704-sec-0092">Appendix 6</a>). </p> </li> </ul> </p> <p>Medical subject headings (MeSH) or equivalent and text word terms were used. Where appropriate, MeSH terms and other subject headings were exploded. We applied a modified version of the Cochrane filter for the identification of RCTs, as published in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012704-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). Searches were tailored to individual databases. </p> </section> <section id="CD012704-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We searched ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) and the World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) for ongoing trials. In addition, we checked the bibliographic references and cited sources of any relevant identified studies to find additional trials not identified by the electronic searches. To identify any unpublished or grey literature, we searched the Internet, using the Google Scholar search engine (<a href="http://www.googlescholar.com" target="_blank">www.googlescholar.com</a>), with selected terms from the above strategy. If only the abstract was published, we attempted to contact the authors for further details, or source the unpublished paper. One of the review authors (KR), who is an Information Specialist, conducted the searches. All searches are current as of 25 January 2018. </p> </section> </section> <section id="CD012704-sec-0029"> <h3 class="title" id="CD012704-sec-0029">Data collection and analysis</h3> <section id="CD012704-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Four review authors (JH, PG, PVB, JD) independently assessed the titles and abstracts of all studies identified by the search for potential inclusion. Each of these authors independently selected all potentially relevant studies for inclusion by applying the selection criteria outlined in the 'Criteria for considering studies for this review' section. We then compared these lists, discussed any differences and either included or excluded the papers based on a majority decision. A PRISMA study flow diagram is included in <a href="#CD012704-fig-0001">Figure 1</a> (<a href="./references#CD012704-bbs2-0077" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097.">Moher 2009</a>), which documents the screening process as recommended in Part 2, Section 11.2.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012704-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <div class="figure" id="CD012704-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram." data-id="CD012704-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> </div> </section> <section id="CD012704-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (AH, SK, JD) independently extracted data using a standard form, and checked for agreement before entry into Review Manager 5 (<a href="./references#CD012704-bbs2-0085" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). The authors extracted data that included information about the year of the study, study design, number of participants treated, participant demographic details, type of cancer, drug and dosing regimen, study design (placebo or active control) and methods, study duration and follow‐up, outcome measures (measurement of dyspnoea and other relevant outcomes), withdrawals and adverse events. We resolved potential disagreements by discussion. </p> </section> <section id="CD012704-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Five review authors (AH, SK, JH, PG, JD) independently assessed the risk of bias of each included study using the 'Risk of bias' assessment method outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012704-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We resolved potential disagreements by discussion. For each study, we assessed the risk of bias for the following domains. </p> <p> <ul id="CD012704-list-0007"> <li> <p>Random sequence generation (checking for selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, e.g. random number table; computer random number generator); or unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (e.g. odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for selection bias). The method used to conceal allocation to interventions prior to assignment determines whether intervention allocation could have been foreseen in advance of, or during, recruitment, or changed after assignment. We assessed the methods as: low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); unclear risk of bias (method not clearly stated). We excluded studies that did not conceal allocation (e.g. open list). </p> </li> <li> <p>Blinding of participants and personnel (checking for performance bias). We assessed the methods used to blind study participants and personnel from knowledge of which intervention a participant received. We assessed methods as: low risk of bias (study stated that it was blinded and described the method used to achieve blinding, such as identical tablets matched in appearance or smell, or a double‐dummy technique); unclear risk of bias (study stated that it was blinded but did not provide an adequate description of how it was achieved). Studies that were not double‐blinded were considered to have high risk of bias. </p> </li> <li> <p>Blinding of outcome assessment (checking for detection bias). We assessed the methods used to blind study participants and outcome assessors from knowledge of which intervention a participant received. We assessed the methods as: low risk of bias (study had a clear statement that outcome assessors were unaware of treatment allocation, and ideally described how this was achieved); unclear risk of bias (study stated that outcome assessors were blind to treatment allocation but lacked a clear statement on how it was achieved). Studies where outcome assessment was not blinded were considered as having a high risk of bias. </p> </li> <li> <p>Incomplete outcome data (checking for attrition bias due to the amount, nature and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk (less than 10% of participants did not complete the study or investigators used 'baseline observation carried forward' analysis, or both); unclear risk of bias (investigators used 'last observation carried forward' analysis); or high risk of bias (investigators used 'completer' analysis). </p> </li> <li> <p>Selective reporting (checking for reporting bias). We assessed whether primary and secondary outcome measures were prespecified, and whether they were consistent with those reported. We assessed the methods as: low risk of bias (study protocol was available and all of the study's prespecified primary and secondary outcomes that were of interest were reported in the prespecified way, or if the study protocol was not available but it was clear that the published reports included all expected outcomes, including those that were prespecified); high risk of reporting bias (not all of the study's prespecified primary outcomes were reported; one or more primary outcomes were reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not prespecified; one or more reported primary outcomes were not prespecified (unless clear justification for their reporting was provided, such as an unexpected adverse effect); one or more outcomes of interest in the review were reported incompletely so that they could not be entered into a meta‐analysis; the study report did not include results for a key outcome that would be expected to have been reported for such a study. </p> </li> <li> <p>Size of study (checking for bias confounded by small size). We assessed studies as being at low risk of bias (200 or more participants per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm); or high risk of bias (fewer than 50 participants per treatment arm). </p> </li> </ul> </p> </section> <section id="CD012704-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes between groups, we estimated and compared the risk ratio (RR) and 95% confidence intervals (CIs). For continuous outcomes, we measured arithmetic mean and standard deviation (SD) and reported the mean difference (MD) between groups, with 95% CI. When an outcome was derived with different instruments measuring the same construct, we used the SMD with 95% CIs. </p> </section> <section id="CD012704-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>We only included studies that randomised individual participants. For trials containing multiple arms, we only included pair‐wise comparisons of each intervention arm to the control arm. </p> </section> <section id="CD012704-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>We ascertained how the investigators analysed the data from withdrawals, where possible. It was not possible to assess the impact of missing data in sensitivity analyses due to the low study numbers. In all cases, we aimed to perform intention‐to‐treat (ITT) analyses. </p> </section> <section id="CD012704-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>There may be an effect of differences between participants, environment (inpatient versus outpatient) and outcome measures. We assessed heterogeneity by using the I² statistic. We considered I² values above 50% to represent substantial heterogeneity, in line with <a href="./references#CD012704-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>, and attempted to assess potential sources of heterogeneity through subgroup analyses. </p> </section> <section id="CD012704-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>We had planned to interpret the results in light of a visual inspection of a funnel plot, but were unable to do so due to the lack of studies. </p> </section> <section id="CD012704-sec-0038"> <h4 class="title">Data synthesis</h4> <p>We entered the data extracted from the included studies into Review Manager 5, which we used for data synthesis (<a href="./references#CD012704-bbs2-0085" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We had planned to pool data for each continuous outcome and calculate the MD as an estimate of effect size, using a random‐effects model with 95% CIs, but were unable to do so due to the lack of studies. </p> <section id="CD012704-sec-0039"> <h5 class="title">Quality of the evidence</h5> <p>Two review authors (AH, SK) planned to independently rate the quality of evidence for dyspnoea relief using the three 'Domains of Dyspnoea Measurement' of dyspnoea, serious adverse events, participant satisfaction with treatment, and participant withdrawal from trial. We used the GRADE system to assess the quality of the available evidence using the GRADEpro Guideline Development Tool software (<a href="./references#CD012704-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 21 June 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT 2015</a>), and the guidelines provided in Chapter 12.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012704-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We presented the findings in a 'Summary of findings' table. </p> <p>The GRADE approach employs five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The GRADE system defines the quality of a body of evidence as the extent to which one can be confident of an estimate of effect, namely: </p> <p> <ul id="CD012704-list-0008"> <li> <p>high: we are very confident that the true effect lies close to that of the estimate of the effect; </p> </li> <li> <p>moderate: we are moderately confident that the true effect lies close to that of the estimate of the effect; </p> </li> <li> <p>low: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect; </p> </li> <li> <p>very low: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>The GRADE system uses the following criteria for assigning a quality level to a body of evidence (Chapter 12, <a href="./references#CD012704-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <p> <ul id="CD012704-list-0009"> <li> <p>High: randomised trials or double‐upgraded observational studies.</p> </li> <li> <p>Moderate: downgraded randomised trials or upgraded observational studies.</p> </li> <li> <p>Low: double‐downgraded randomised trials or observational studies.</p> </li> <li> <p>Very low: triple‐downgraded randomised trials, downgraded observational studies or case series/case reports. </p> </li> </ul> </p> <p>Factors that may decrease the quality level of a body of evidence are:</p> <p> <ul id="CD012704-list-0010"> <li> <p>limitations in the design and implementation of available studies suggesting high likelihood of bias; </p> </li> <li> <p>indirectness of evidence (indirect population, intervention, control, outcomes);</p> </li> <li> <p>unexplained heterogeneity or inconsistency of results (including problems with subgroup analyses); </p> </li> <li> <p>imprecision of results (wide CIs);</p> </li> <li> <p>high probability of publication bias.</p> </li> </ul> </p> <p>Factors that may increase the quality level of a body of evidence are:</p> <p> <ul id="CD012704-list-0011"> <li> <p>large magnitude of effect;</p> </li> <li> <p>all plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect; </p> </li> <li> <p>dose–response gradient.</p> </li> </ul> </p> <p>We decreased the grade rating by one (–1) or two (–2) (up to a maximum of –3 to 'very low') for: </p> <p> <ul id="CD012704-list-0012"> <li> <p>serious (–1) or very serious (–2) limitation to study quality;</p> </li> <li> <p>important inconsistency (–1);</p> </li> <li> <p>some (–1) or major (–2) uncertainty about directness;</p> </li> <li> <p>imprecise or sparse data (–1); or</p> </li> <li> <p>high probability of reporting bias (–1).</p> </li> </ul> </p> </section> <section id="CD012704-sec-0040"> <h5 class="title">'Summary of findings' table</h5> <p>We included a ‘Summary of findings’ table to present the main findings in a transparent and simple tabular format. In particular, we included key information concerning the quality of evidence, the magnitude of effect of the interventions examined, and the sum of available data on dyspnoea relief, as measured by the three domains of dyspnoea, i.e. intensity of dyspnoea (sensory‐perceptual experience, as measured by ratings of breathlessness intensity), quality of dyspnoea (affective distress, as measured by ratings of severity of distress), and burden of breathlessness/impact on function (as measured by ratings of functional ability, quality of life or health status), adverse events, patient satisfaction with treatment, and participant withdrawal from trial. </p> </section> </section> <section id="CD012704-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>There were insufficient data available to perform subgroup analyses based on type of systemic corticosteroid, dose, type of cancer and length of the trial. </p> </section> <section id="CD012704-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to examine the robustness of the meta‐analyses by conducting sensitivity analyses using different components of the 'Risk of bias' assessment – particularly those relating to selection bias, and trial size, to see if any of these factors influenced the results. We had also planned to investigate variation across studies (heterogeneity) by comparing a random‐effects model with a fixed‐effect model. We were unable to perform any sensitivity analyses due to the low number of studies included in the meta‐analysis, and the small number of participants in each comparison. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012704-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012704-sec-0043"></div> <section id="CD012704-sec-0044"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD012704-sec-0103" title="">Characteristics of included studies</a> and <a href="./references#CD012704-sec-0104" title="">Characteristics of excluded studies</a> tables. </p> <section id="CD012704-sec-0045"> <h4 class="title">Results of the search</h4> <p>The PRISMA diagram outlines the number of records identified in the search and screening process for these papers (<a href="#CD012704-fig-0001">Figure 1</a>). In the initial database search, we identified 1350 records. None were identified through other sources. Of these, 285 were duplicates and we rejected 1047 based on information given in the title and abstract. We identified 18 publications for full‐text retrieval, and excluded 16 of these records during screening. The reasons for exclusion of each study are described in the <a href="./references#CD012704-sec-0104" title="">Characteristics of excluded studies</a> table. Two placebo‐controlled studies met the inclusion criteria for this review (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). We evaluated the results relative to dyspnoea intensity/dyspnoea relief at one week from baseline (day seven and eight), since this was the only time that could be standardised across both trials. </p> </section> <section id="CD012704-sec-0046"> <h4 class="title">Included studies</h4> <p>We identified two studies meeting the inclusion criteria (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). These two studies enrolled 157 participants (37 and 120 participants per study), of whom 114 were included in the analyses. The studies compared oral dexamethasone to placebo. One study lasted seven days, and the duration of the other study was 15 days. A detailed description of the included studies can be found in the <a href="./references#CD012704-sec-0103" title="">Characteristics of included studies</a> table. </p> <section id="CD012704-sec-0047"> <h5 class="title">Primary disease sites</h5> <p>We have shown the primary disease sites in <a href="#CD012704-tbl-0002">Table 1</a>. Eligibility criteria in the included trials did not specify a particular cancer. </p> <div class="table" id="CD012704-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Primary sites of disease</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Breast</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Head, neck and lung</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Gastrointestinal</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Gynaecological</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Genitourinary</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Sarcoma</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Not specified</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD012704-sec-0048"> <h5 class="title">Types of studies</h5> <p>We included studies in which corticosteroids were used for cancer‐related dyspnoea, or any other indication. The studies assessed dyspnoea relief intensity, quality and burden/impact on function. </p> </section> <section id="CD012704-sec-0049"> <h5 class="title">Dyspnoea as a primary endpoint</h5> <p>Of the two included studies, one measured change in dyspnoea intensity as a primary endpoint (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). The other study measured fatigue (a change in the Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT‐F) subscale) as the primary outcome (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). </p> </section> <section id="CD012704-sec-0050"> <h5 class="title">Types of corticosteroids studied</h5> <p>Both studies used oral dexamethasone. One study compared dexamethasone (8 mg twice a day for four days, then 4 mg twice a day for three days) to placebo (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). The other study compared dexamethasone (8 mg/day) to placebo (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). </p> </section> <section id="CD012704-sec-0051"> <h5 class="title">Dyspnoea measurement tools</h5> <p>The studies used different measurement tools to measure dyspnoea relief intensity, quality, burden/impact on function and quality of life. </p> <p> <ul id="CD012704-list-0013"> <li> <p>Dyspnea Numeric Rating Scale 'now' (NRS) 0 to 10 (0 = no shortness of breath) (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). </p> </li> <li> <p>Edmonton Symptom Assessment Scale (ESAS) 0 to 10 (0 = no shortness of breath) – dyspnoea mean past 24 hours; fatigue, drowsiness and appetite (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). </p> </li> <li> <p>Modified Dyspnea Borg Scale (0 to 10) (0 = no shortness of breath at all) (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). </p> </li> <li> <p>Cancer Dyspnea Scale 1 to 5 (higher score indicates a greater intensity of dyspnoea) (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). </p> </li> <li> <p>European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire‐Core 30 – dyspnoea past week (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). </p> </li> <li> <p>Global Symptom Evaluation (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). </p> </li> </ul> </p> </section> </section> <section id="CD012704-sec-0052"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 studies and provided reasons for exclusion in the <a href="./references#CD012704-sec-0104" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD012704-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed each study using the Cochrane 'Risk of bias' tool. We presented overall findings in the 'Risk of bias' graph (<a href="#CD012704-fig-0002">Figure 2</a>), which presents the authors' judgements about each risk of bias domain as percentages across all included studies. We have shown the authors' judgements about each risk of bias domain for each included study in the 'Risk of bias' summary (<a href="#CD012704-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD012704-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012704-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012704-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012704-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012704-sec-0054"> <h4 class="title">Allocation</h4> <section id="CD012704-sec-0055"> <h5 class="title">Random sequence generation</h5> <p>Both included studies reported that they were randomised. Only one study described the method used to generate their random sequence (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>), thus we judged the second study to have an unclear risk of bias (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). </p> </section> <section id="CD012704-sec-0056"> <h5 class="title">Allocation concealment</h5> <p>For allocation concealment, only one study used pharmacy randomisation and was at low risk in this regard (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). The other study was at unclear risk, as there was insufficient information on the method of allocation concealment (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). </p> </section> </section> <section id="CD012704-sec-0057"> <h4 class="title">Blinding</h4> <p>Both studies were at low risk, with blinding of participants, personnel and outcome assessments reported (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). </p> </section> <section id="CD012704-sec-0058"> <h4 class="title">Incomplete outcome data</h4> <p>The two studies were at high risk for attrition bias, as greater than 10% of participants could not be evaluated, thereby leaving a gap in the evidence (i.e. 6/19 participants receiving the intervention and 3/18 participants receiving placebo (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>); 19/62 participants receiving the intervention, and 17/58 participants receiving placebo (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>)). </p> </section> <section id="CD012704-sec-0059"> <h4 class="title">Selective reporting</h4> <p>Neither study identified reporting gaps. Therefore, we judged these studies at low risk for reporting bias. </p> </section> <section id="CD012704-sec-0060"> <h4 class="title">Other potential sources of bias</h4> <p>Small studies are thought to be at increased risk of bias as they are unlikely to be adequately powered. Neither study was large enough to be at low risk of bias (more than 200 participants per arm). We judged one study to have an unclear risk of bias due to sample size (50 to 199 participants per arm) (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). The other study was at high risk of bias because of their small number of participants (fewer than 50 participants per treatment arm) (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). </p> </section> </section> <section id="CD012704-sec-0061"> <h3 class="title" id="CD012704-sec-0061">Effects of interventions</h3> <p>See: <a href="./full#CD012704-tbl-0001"><b>Summary of findings 1</b> Systemic corticosteroids compared with placebo for the management of cancer‐related breathlessness (dyspnoea)</a> </p> <section id="CD012704-sec-0062"> <h4 class="title">Primary outcome</h4> <section id="CD012704-sec-0063"> <h5 class="title">Participant‐reported dyspnoea intensity, quality and burden</h5> <p>For the meta‐analysis, both studies provided change in dyspnoea intensity score (on a scale of 0 to 10; lower score = less breathlessness) and the standard deviation at one week (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). The studies included 157 participants at baseline and 114 participants after one week of corticosteroid treatment (dexamethasone). After one week, the dexamethasone group reported less dyspnoea intensity than the control group (MD –0.85, 95% CI –1.73 to 0.03; P = 0.06; <a href="./references#CD012704-fig-0004" title="">Analysis 1.1</a>), although we were uncertain as to whether corticosteroids truly had an important effect on dyspnoea as results were imprecise. </p> <p>Both studies used a numeric rating scale to assess the intensity of dyspnoea 'now' – an 11‐point dyspnoea numeric rating scale (0 to 10). </p> <p>We judged the quality of the evidence for the primary outcome of dyspnoea relief (intensity) to be very low (see <a href="./full#CD012704-tbl-0001">summary of findings Table 1</a>). We downgraded the quality of the evidence once for imprecision due to the small number of participants in the included studies, and twice for very serious study limitations (likely selection and attrition bias). </p> <p>One study measured affective distress/quality of dyspnoea (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>), using the Cancer Dyspnea Scale effort, discomfort and anxiety variables (Domain 2 of Parshall's 'Domains of Dyspnoea Measurement') and results were similar between groups. We judged the quality of the evidence for the primary outcome of dyspnoea relief (quality) to be very low. We downgraded the quality of the evidence three times for imprecision due to the small number of participants in the included study, inconsistency, and serious study limitations (likely attrition bias). </p> <p>Both studies assessed impact of dyspnoea on function/quality of life. <a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a> assessed dyspnoea quality and burden/impact on function and quality of life using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 36 (EORTC QLQ‐C30) dyspnoea 'past week,' which favoured dexamethasone compared to placebo at day four, but not at day seven. However, it was unclear whether dexamethasone had a significant effect on dyspnoea as results were imprecise. In <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>, FACIT physical well‐being scores showed significantly better improvement at days eight (P = 0.007) and 15 (P = 0.002) in the dexamethasone group compared with the control group, however there were no significant changes for FACIT social/family, emotional or functional scales. We judged the quality of the evidence for the primary outcome of dyspnoea relief (burden) to be very low. We downgraded the quality of the evidence three times for imprecision due to the small number of participants in the included studies, inconsistency, and serious study limitations (likely selection and attrition bias). </p> </section> </section> <section id="CD012704-sec-0064"> <h4 class="title">Secondary outcomes</h4> <section id="CD012704-sec-0065"> <h5 class="title">Serious adverse events</h5> <p>The severity of adverse events was not properly defined, making it difficult to assess this outcome. Hence we evaluated reported ‘adverse events’. In both studies, the frequency of adverse events was similar between groups, and dexamethasone was generally well tolerated. We judged the quality of the evidence for this outcome to be very low. We downgraded the quality of the evidence three times due to serious study limitations (likely selection and attrition bias), inconsistency, and imprecision due to the small number of participants in the included studies. </p> </section> <section id="CD012704-sec-0066"> <h5 class="title">Participant satisfaction with treatment</h5> <p>Neither study measured participant satisfaction with treatment.</p> </section> <section id="CD012704-sec-0067"> <h5 class="title">Participant withdrawal</h5> <p>There were 6/41 (15%) participant withdrawals in <a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>, and 48/132 (36%) in <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>. We judged the quality of the evidence for this outcome to be very low. We downgraded the quality of the evidence three times from high to very low due to serious study limitations (likely selection and attrition bias), inconsistency, and imprecision due to the small number of participants in the included studies. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012704-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012704-sec-0068">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012704-sec-0167">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012704-sec-0068"></div> <section id="CD012704-sec-0069"> <h3 class="title" id="CD012704-sec-0069">Summary of main results</h3> <p>The objective of this systematic review was to assess the effects of corticosteroids on dyspnoea in adults with cancer‐related dyspnoea. Two studies with 157 participants met the inclusion criteria, of whom 114 were evaluable. The included studies assessed dexamethasone (4 mg/day or up to 16 mg/day) compared to placebo. </p> <p>Both studies were evaluated for relief of dyspnoea in the meta‐analysis (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). We reported data after one week of intervention, since this was the only time that could be standardised across both trials. The following conclusion regarding the effectiveness of corticosteroids for relief of dyspnoea should be interpreted with consideration of the small number of eligible studies with small numbers of participants in each treatment arm, and difference in dexamethasone dose. The quality of evidence was very low due to very serious study limitations and imprecision. </p> <p> <ul id="CD012704-list-0014"> <li> <p>There was no clear difference in favour of dexamethasone over placebo (MD –0.85, 95% –1.73 to 0.03) for dyspnoea at one week of intervention (P = 0.06). </p> </li> <li> <p>There were insufficient data to evaluate different subgroups, such as drug type, route of administration, dosage and different primary disease types. </p> </li> </ul> </p> </section> <section id="CD012704-sec-0070"> <h3 class="title" id="CD012704-sec-0070">Overall completeness and applicability of evidence</h3> <p>We identified two studies that met the inclusion criteria and included these studies in the meta‐analysis for dyspnoea relief/change in dyspnoea intensity from baseline. There was a lack of studies for planned comparisons, and insufficient data for subgroup analyses. The results were also influenced by differences in dosages, comparators and heterogeneity of study populations. The studies excluded people with overlying conditions that would be expected to respond to corticosteroids (e.g. COPD and superior vena cava obstruction). Comparators included in the meta‐analysis included dexamethasone compared to placebo. We also included trials where dyspnoea was not the primary outcome. </p> </section> <section id="CD012704-sec-0071"> <h3 class="title" id="CD012704-sec-0071">Quality of the evidence</h3> <p>The quality of evidence for breathlessness intensity was very low, downgraded once for imprecision due to the small number of participants in the included studies, and twice for very serious study limitations (likely selection and attrition bias). Both studies measured participant‐reported dyspnoea relief/intensity of dyspnoea at similar time points, and burden of dyspnoea/impact on function and quality of life (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>; <a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). Only one study measured affective distress/quality of dyspnoea (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). We judged the quality of the evidence for the outcomes breathlessness quality and burden to be very low, downgraded three times for imprecision due to the small number of participants in the included studies, inconsistency, and serious study limitations. </p> <p>We judged the quality of the evidence for the outcomes adverse events and withdrawals to be very low, downgraded three times due to serious study (likely selection and attrition bias), inconsistency, and imprecision due to the small number of participants in the included studies. Neither study measured participant satisfaction with treatment. </p> <p>Other concerns regarding quality of the evidence included the fact that one study was an inadequately powered pilot study with greater than 10% dropouts in both arms prior to day seven (<a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a>). The other study had a very high participant withdrawal from trial, with approximately 30% dropouts by day 15 (<a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a>). Therefore, the current body of evidence does not allow a robust conclusion. We have very little confidence in the effect estimate, and the true effect is likely to be substantially different from the estimate of effect. </p> </section> <section id="CD012704-sec-0072"> <h3 class="title" id="CD012704-sec-0072">Potential biases in the review process</h3> <p>To minimise bias, three review authors independently extracted data and five authors assessed risk of bias. Due to the lack of studies we were unable to determine if there was evidence of small‐study effects. </p> </section> <section id="CD012704-sec-0073"> <h3 class="title" id="CD012704-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>We found no other studies or reviews that assessed the quality of evidence and effects of systemic corticosteroid use for the management of cancer‐related dyspnoea in adults. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012704-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/urn:x-wiley:14651858:media:CD012704:CD012704-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram." data-id="CD012704-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_t/tCD012704-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012704-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/urn:x-wiley:14651858:media:CD012704:CD012704-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012704-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_t/tCD012704-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012704-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/urn:x-wiley:14651858:media:CD012704:CD012704-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012704-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_t/tCD012704-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012704-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/urn:x-wiley:14651858:media:CD012704:CD012704-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Breathlessness (dyspnoea) at one week, Outcome 1: Breathlessness (dyspnoea)" data-id="CD012704-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_t/tCD012704-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Breathlessness (dyspnoea) at one week, Outcome 1: Breathlessness (dyspnoea)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/references#CD012704-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/media/CDSR/CD012704/image_n/nCD012704-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012704-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Systemic corticosteroids compared with placebo for the management of cancer‐related breathlessness (dyspnoea)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Systemic corticosteroids compared with placebo for</b> <b>the management of cancer‐related breathlessness (dyspnoea)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with cancer‐related breathlessness (dyspnoea) </p> <p><b>Settings:</b> inpatients and outpatients </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Breathlessness (dyspnoea) at 1 week (intensity)</b> </p> <p>Scale 0–10;</p> <p>lower score = less breathlessness</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score for intensity of breathlessness at baseline was 4.7 and 3 for the control groups. </p> <p>The mean difference in the intensity of breathlessness at 1 week was –1.3 and –0.58 for the control groups. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score for intensity of breathlessness at baseline was 5.0 and 4.09 for the intervention groups. </p> <p>The mean difference in the intensity of breathlessness at 1 week was –1.8 and –1.56 for the intervention groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Breathlessness (dyspnoea) at 1 week (quality)</b> </p> <p>Cancer Dyspnea Scale</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Small reduction in effort, discomfort and anxiety.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Small reduction in effort and anxiety, with a slight increase in discomfort.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Breathlessness (dyspnoea) at 1 week (burden)</b> </p> <p>EORTC QLQ‐C30, FACIT, ESAS</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Different measurement tools used in each study. Significant reduction in burden at 1 week for dexamethasone group compared to control group observed only for the FACIT physical subscale in one study. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Severity of adverse events was not properly defined making it difficult to assess this outcome. The frequency of adverse events was similar between groups. The intervention was well tolerated in corticosteroid group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>157</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction with treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to GRADE this outcome due to a lack of data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant withdrawal from trial</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>54 withdrawals out of 173 participants (31%) for the two studies. Rate of withdrawal was similar between placebo and dexamethasone groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CI:</b> confidence interval. </p> <p>GRADE Working Group grades of evidence</p> <p><b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect; </p> <p><b>Moderate quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different; </p> <p><b>Low quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect; </p> <p><b>Very low quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded the quality of the evidence once for imprecision due to the small number of participants in the included studies, and twice for very serious study limitations (likely selection and attrition bias). </p> <p><sup>b</sup>Downgraded the quality of the evidence three times: once for imprecision due to the small number of participants in the included study, once for inconsistency, and once for serious study limitations (likely attrition bias). </p> <p><sup>c</sup>Downgraded the quality of the evidence three times: once for imprecision due to the small number of participants in the included studies, once for inconsistency, and once for serious study limitations (likely selection and attrition bias). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Systemic corticosteroids compared with placebo for the management of cancer‐related breathlessness (dyspnoea)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012704-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Primary sites of disease</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Breast</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Head, neck and lung</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Gastrointestinal</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Gynaecological</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Genitourinary</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Sarcoma</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Not specified</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012704-bbs2-0001" title="HuiD , KilgoreK , Frisbee-HumeS , ParkM , TsaoA , Delgado GuayM , et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. Journal of Pain and Symptom Management2016;52(1):8-16. ">Hui 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012704-bbs2-0002" title="YennurajalingamS , Frisbee-HumeS , PalmerJL , Delgado-GuayMO , BullJ , PhanAT , et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology2013;31(25):3076-82. ">Yennurajalingam 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Primary sites of disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/full#CD012704-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012704-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Breathlessness (dyspnoea) at one week</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Breathlessness (dyspnoea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.85 [‐1.73, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Breathlessness (dyspnoea) at one week</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012704.pub2/references#CD012704-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012704.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012704-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012704-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012704-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012704-note-0011">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012704-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012704-note-0010">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012704-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012704-note-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012704-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012704\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012704\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012704\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012704\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012704\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012704.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012704.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012704.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012704.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012704.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726930957"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012704.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726930961"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012704.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9fb158a3f480',t:'MTc0MDcyNjkzMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 